Selection of nanobodies that target human neonatal fc receptor

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Andersen, Jan Terje ^a,b   Gonzalez Pajuelo, Maria ^c   Foss, Stian ^a,b   Landsverk, Ole J B ^a   Pinto, Débora ^c   Szyroki, Alexander ^c   De Haard, Hans J ^c   Saunders, Michael ^c,d   Vanlandschoot, Peter ^c,e   Sandlie, Inger ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ABLYNX NV   (Belgium)

^d ArGEN X BVBA   (Belgium)

^e NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FC RECEPTOR, NEONATAL; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN G; LIGAND; NANOBODY;

ANIMAL; ARTICLE; ARTIODACTYLA; CELL STRAIN HEK293; HAPLORHINI; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; PH; RAT; SWINE; TRANSCYTOSIS; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CAMELIDS, NEW WORLD; HAPLORHINI; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULIN G; LIGANDS; MICE; RATS; RECEPTORS, FC; SINGLE-DOMAIN ANTIBODIES; SWINE; TRANSCYTOSIS;

EID: 84873132485     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01118     Document Type: Article

References (40)

1. Rodewald, R. & Kraehenbuhl, J. P. Receptor-mediated transport of IgG. J Cell Biol 99, 159s-164s (1984). (Pubitemid 14030792)
2. Simister, N. E. &Mostov, K. E. An Fc receptor structurally related to MHC class I antigens. Nature 337, 184-187 (1989). (Pubitemid 19025381)
3. Roopenian, D. C. & Akilesh, S. FcRn: the neonatal Fc receptor comes of age. Nature reviews. Immunology 7, 715-725 (2007). (Pubitemid 47327396)
4. Ward, E. S. & Ober, R. J. Chapter 4: Multitasking by exploitation of intracellular transport functions themany faces of FcRn. Advances in immunology 103, 77-115 (2009).
5. Stapleton, N. M. et al. Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nature communications 2, 599 (2011).
6. Kim, J. K. et al. Mapping the site on human IgG for binding of the MHC class Irelated receptor, FcRn. European journal of immunology 29, 2819-2825 (1999).
7. Chaudhury, C. et al. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. The Journal of experimental medicine 197, 315-322 (2003). (Pubitemid 36184238)
8. Morell, A., Terry, W. D. & Waldmann, T. A. Metabolic properties of IgG subclasses in man. J Clin Invest 49, 673-680 (1970).
9. Peters, T., Jr. Serum albumin. Advances in protein chemistry 37, 161-245 (1985).
10. Montoyo, H. P. et al. Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice. Proceedings of the National Academy of Sciences of the United States of America 106, 2788-2793 (2009).
11. Akilesh, S., Christianson, G. J., Roopenian, D. C. & Shaw, A. S. Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism. J Immunol 179, 4580-4588 (2007).
12. Kobayashi, K. et al. An FcRn-dependent role for anti-flagellin immunoglobulin G in pathogenesis of colitis in mice. Gastroenterology 137, 1746-1756 e1741 (2009).
13. Spiekermann, G.M. et al. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. The Journal of experimental medicine 196, 303-310 (2002). (Pubitemid 34875660)
14. Bitonti, A. J. et al. Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. Proc Natl Acad Sci USA 101, 9763-9768 (2004). (Pubitemid 38869310)
15. Story, C. M.,Mikulska, J. E. & Simister, N. E. Amajor histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J Exp Med 180, 2377-2381 (1994). (Pubitemid 24351622)
16. Firan, M. et al. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. International immunology 13, 993-1002 (2001). (Pubitemid 32750502)
17. Qiao, S. W. et al. Dependence of antibody-mediated presentation of antigen on FcRn. Proceedings of the National Academy of Sciences of the United States of America 105, 9337-9342 (2008).
18. Baker, K. et al.Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b1 dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 108, 9927-9932 (2011).
19. Burmeister, W. P.,Huber, A. H.&Bjorkman, P. J. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature 372, 379-383 (1994). (Pubitemid 24363442)
20. West, A. P., Jr.&Bjorkman, P. J. Crystal structure and immunoglobulin Gbinding properties of the human major histocompatibility complex-related Fc receptor(,). Biochemistry 39, 9698-9708 (2000). (Pubitemid 30626819)
21. Andersen, J. T. et al. Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor. Nature communications 3, 610 (2012).
22. Andersen, J. T., Dee Qian, J. & Sandlie, I. The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin. European journal of immunology 36, 3044-3051 (2006). (Pubitemid 44782576)
23. Chaudhury, C., Brooks, C. L., Carter, D. C., Robinson, J. M. & Anderson, C. L. Albumin binding to FcRn: distinct from the FcRn-IgG interaction. Biochemistry 45, 4983-4990 (2006).
24. Andersen, J. T., Daba, M. B., Berntzen, G., Michaelsen, T. E. & Sandlie, I. Crossspecies binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding. The Journal of biological chemistry 285, 4826-4836 (2010).
25. Andersen, J. T. & Sandlie, I. The versatile MHC class I-related FcRn protects IgG and albumin from degradation: implications for development of new diagnostics and therapeutics. Drug metabolism and pharmacokinetics 24, 318-332 (2009).
26. Kuo, T. T. et al. Neonatal Fc receptor: from immunity to therapeutics. Journal of clinical immunology 30, 777-789 (2010).
27. Van Bockstaele, F., Holz, J. B. & Revets, H. The development of nanobodies for therapeutic applications. Curr Opin Investig Drugs 10, 1212-1224 (2009).
28. Claypool, S. M., Dickinson, B. L., Yoshida, M., Lencer, W. I. & Blumberg, R. S. Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human beta 2-microglobulin. The Journal of biological chemistry 277, 28038-28050 (2002). (Pubitemid 34966755)
29. Dickinson, B. L. et al. Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. The Journal of clinical investigation 104, 903-911 (1999). (Pubitemid 29536340)
30. Zalevsky, J. et al. Enhanced antibody half-life improves in vivo activity. Nature biotechnology 28, 157-159 (2010).
31. Andersen, J. T. et al. Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life. The Journal of biological chemistry 287, 22927-22937 (2012).
32. Petkova, S. B. et al. Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRnmouse model: potential application in humorally mediated autoimmune disease. International immunology 18, 1759-1769 (2006). (Pubitemid 44884038)
33. Mezo, A. R. et al. Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn. Proceedings of the National Academy of Sciences of the United States of America 105, 2337-2342 (2008). (Pubitemid 351520514)
34. Yoshida, M. et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20, 769-783 (2004). (Pubitemid 38757446)
35. Andersen, J. T. et al. Extending half-life by indirect targeting of the neonatal Fc receptor (FcRn) using a minimal albumin binding domain. The Journal of biological chemistry 286, 5234-5241 (2011).
36. Andersen, J. T. et al. Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues. The FEBS journal 275, 4097-4110 (2008).
37. Berntzen, G. et al. Prolonged and increased expression of soluble Fc receptors, IgG and a TCR-Ig fusion protein by transiently transfected adherent 293E cells. Journal of immunological methods 298, 93-104 (2005). (Pubitemid 40545096)
38. Andersen, J. T. et al. A strategy for bacterial production of a soluble functional human neonatal Fc receptor. J Immunol Methods 331, 39-49 (2008).
39. Roovers, R. C. et al. Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies. Cancer Immunol Immunother 56, 303-317 (2007). (Pubitemid 46035901)
40. Daley, L. P., Gagliardo, L. F., Duffy, M. S., Smith, M. C. & Appleton, J. A. Application of monoclonal antibodies in functional and comparative investigations of heavy-chain immunoglobulins in new world camelids. Clin Diagn Lab Immunol 12, 380-386 (2005). (Pubitemid 41175333)